Ursprung des Netzwerks ersten Grades von Teymuras Kurzchalia
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
JADO Technologies GmbH
 JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany.
8
| Extinct | Drugstore Chains | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Teymuras Kurzchalia
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Karlsruhe | College/University | Director/Board Member Doctorate Degree | |
Isarna Therapeutics GmbH
 Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Biotechnology | Founder | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
| Henley Business School Ltd. | College/University | Masters Business Admin | |
| BAYER AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
UCB Celltech
 UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | Biotechnology | Director/Board Member | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Cape Town | College/University | Undergraduate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
AudioCure Pharma GmbH
 AudioCure Pharma GmbH Pharmaceuticals: MajorHealth Technology AudioCure Pharma GmbH provides preclinical research and clinical development of novel pharmacotherapies to treat disorders of the inner ear. It engages in the clinical development of drug candidates in neurodegenerative disease indications. The firm's offer medicine for the treatment of acute and chronic hearing impairments via local, regenerative therapy of the damaged nerve cells in the inner ear. The company was founded by Hans Rommelspacher in 2010 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
| Hanover College | College/University | Corporate Officer/Principal | |
| Dresden University of Technology | College/University | Corporate Officer/Principal | |
Ribonetics GmbH
 Ribonetics GmbH BiotechnologyHealth Technology Part of Baxter International, Inc., Ribonetics GmbH is a German company that develops RILON technology, a therapeutic treatment. The company is located in Germany. Ribonetics was acquired by Nexell Therapeutics, Inc. on May 23, 1996 for $1.50 million. | Biotechnology | Corporate Officer/Principal | |
HepaVec AG
 HepaVec AG Pharmaceuticals: MajorHealth Technology Part of Evotec SE, HepaVec AG is a German pharmaceutical company that develops pharmaceutical products. The company is based in Berlin, Germany. HepaVec was acquired by DeveloGen AG on May 01, 2000 for $46.57 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of York | College/University | Doctorate Degree | |
| University of Trieste | College/University | Doctorate Degree | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The European Molecular Biology Laboratory | College/University | Corporate Officer/Principal | |
| University of Helsinki | College/University | Doctorate Degree | |
| Max-Planck-Institute for Molecular Genetics | College/University | Corporate Officer/Principal |
Statistik
International
| Deutschland | 11 |
| Vereinigte Staaten | 7 |
| Vereinigtes Königreich | 4 |
| Belgien | 4 |
| Dänemark | 2 |
Sektoral
| Health Technology | 16 |
| Consumer Services | 11 |
| Commercial Services | 3 |
Operativ
| Corporate Officer/Principal | 14 |
| Founder | 5 |
| Chief Executive Officer | 4 |
| Doctorate Degree | 4 |
| Director/Board Member | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Teymuras Kurzchalia
- Unternehmensverbindungen
